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Abstract cGMP has been shown to either activate or inhibit
Na,K-ATPase activity. Using mouse brain endothelial cells
which express both ouabain-resistant K1 and ouabain-sensitive
K2 and K3 isoforms, we show that cGMP reduces total Na,K-
ATPase activity to about 58%. The inhibition is prevented by the
protein kinase G (PKG)-specific inhibitor KT5823, indicating
that cGMP-mediated activation of PKG leads to inhibition of the
pump. A similar extent of inhibition is obtained with nitric oxide.
cGMP-induced inhibition acts mainly on K1 isoforms but hardly
affects K2/K3 isoforms. These data suggest that inhibition of
Na,K-ATPase activity by cGMP occurs in an isoform-selective
manner in brain endothelial cells.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The Na,K-ATPase is responsible for maintaining the elec-
trochemical gradient of sodium and potassium ions and plays
an important role in the regulation of the ionic homeostasis in
tissues and cells [1]. The enzyme is composed of a catalytic K
subunit and a L subunit glycoprotein which is essential for
enzyme maturation [2]. For each subunit three isoforms, en-
coded by individual genes, have been discovered. This multi-
plicity allows the formation of, theoretically, nine di¡erent
isoenzymes.
All K and L subunit isoforms exhibit a complex tissue-spe-
ci¢c expression pattern [3]. The temporal and spatial expres-
sion in brain even demonstrates that multiple K and L iso-
forms are simultaneously expressed in the same cell type [4^6],
suggesting the concurrent presence of several sodium pump
isoenzymes. For example, brain microvessels and ependymal
cells of the choroid plexus express (at least) ¢ve isoforms [7].
Endothelial cells of microvessels and ependymal cells form the
barriers between the brain and the blood and the cerebrospi-
nal £uid, respectively. These structures are implicated in the
tight control of nutrient and ion £uxes from and into the
brain parenchyma [8] and therefore depend on high Na,K-
ATPase activity. Pump activity in microvessels was ¢rst local-
ised at the abluminal [9] and then at both the luminal and
abluminal side [10]. Interestingly, in this latter study low af-
¢nity ouabain binding sites, characteristic for the K1 isoform
were assigned to the luminal membrane fraction and high
a⁄nity binding sites, de¢ning K2 and K3 isoforms, to the
abluminal one. This result provides evidence for an asymmet-
ric distribution of Na,K-ATPase K subunit isoforms in blood
vessels.
The regulation of Na,K-ATPase activity by exogenous fac-
tors has been widely studied. It is mediated e.g. by hormones,
salts and neurotransmitters [11]. Intracellularly, many of these
signals are likely to modulate phosphorylation of the K sub-
unit by protein kinases A and C and protein phosphatases
[12^14]. A direct linkage between neurotransmitter modula-
tion and K subunit phosphorylation was demonstrated e.g.
in the choroid plexus: serotonin reduced pump activity and
increased the amount of the phosphorylated K subunit [15].
Studies on regulation of Na,K-ATPase activity by protein
kinase G (PKG) provided evidence that cGMP inhibited the
pump in kidney [16,17] and activated it in Purkinje neurons
[18]. Since kidney predominantly expresses the K1 isoform
gene, whereas in Purkinje neurons K3 is mainly found, a tis-
sue- and/or isoform-speci¢c response to cGMP/PKG activa-
tion might underlie these opposite responses. To address this
subject, we have chosen mouse brain endothelial cells which
simultaneously express K1, K2 and K3 isoforms and investi-
gated whether modulation of Na,K-ATPase activity could
occur in an isoform-speci¢c manner in endothelial cells.
2. Materials and methods
2.1. RNA isolation and reverse transcription
For preparation of total RNA, bEnd4 cells were grown to con£u-
ence in a 75-cm2 culture £ask. RNA was isolated by the GTC method
[19]. After dissolution in water, RNA was reextracted with phenol/
chloroform and reprecipitated with sodium acetate and ethanol. The
concentration of the RNA was determined by measuring the absorb-
ance at 260 and 280 nm and the quality was controlled by gel electro-
phoresis. Five Wg total RNA were used for oligodT-primed single-
stranded cDNA synthesis with the superscript preampli¢cation system
(Gibco-BRL). After RNase treatment, the cDNA was stored at
320‡C in aliquots without further treatment.
2.2. PCR ampli¢cation of Na,K-ATPase subunit isoforms
PCR primers were deduced from mouse (L1 and L2) or rat (K1, K2,
K3, L3) sequences. For each primer pair the optimal ampli¢cation
conditions were determined by using the cloned subunit-speci¢c
cDNA as template. The optimisation of the L3 reaction was per-
formed with single stranded cDNA derived from rat C6 glioma cells.
The isoform-speci¢c primers did not crosshybridise with the cDNA
templates coding for the other isoforms and their ampli¢cation e⁄-
ciencies were comparable. No signals were obtained when omitting
the reverse transcription. The ¢nal PCR conditions were: 0.5 Wl
cDNA reaction mix, 30 s denaturation at 94‡C, annealing for 1 min
at the optimal temperature (between 57 and 60‡C), extension at 72‡C
for 60^90 s. The cycles were repeated 40 times, which allowed to
detect a weak signal for K3. For all reactions 1.5 mM MgCl2 was
the optimal concentration. The primer concentrations were 10 WM
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each. The reactions were initiated with a hot-start by addition of 0.2 Wl
Taq-Polymerase (Promega, 5 U/Wl).
2.3. Determination of Na,K-ATPase activity
bEnd4 cells, an SV40-transformed mouse brain capillary endothe-
lioma cell line [20], were grown in DMEM/10% FCS and split with
0.02% trypsin/1 mM EDTA twice a week. For determination of
Na,K-ATPase activity, 0.3U105 cells were seeded per well of a 24-
well plate and incubated for 16 h to reach about 60% con£uence.
Then the cells were washed twice with HEPES-bu¡ered saline
(HBS) (50 mM HEPES, pH 7.4, 127 mM NaCl, 5 mM KCl,
0.8 mM MgSO4, 1 mM MgCl2, 0.25 mM CaCl2) and equilibrated
in 200 Wl of HBS for 15 min at 37‡C. Then the bu¡er was replaced
with 200 Wl of HBS containing the additives 4 mM 8-bromo-cyclic
GMP (8-Br-cGMP), 3 mM nitroso-glutathione, or 2 WM KT5823, as
indicated in the ¢gure legends. Maximal e¡ects of 8-Br-cGMP and
nitroso-glutathione were obtained with these concentrations. Cells
were incubated for 15 min at 37‡C and then rapidly washed three
times with bu¡er without additives. Next the cells were equilibrated
for two min in bu¡er containing ouabain (15 mM or 10 WM, respec-
tively, to distinguish between low and high a⁄nity binding sites),
followed by the addition of 1.5 WCi/ml [86Rb]-chloride (Amersham,
sp. act. 100 Ci/mmol) and incubation for 15 min. Uptake of Rb was
linear under these conditions for at least 40 min. The reaction was
stopped by aspiration of the bu¡er and four wash steps with ice-cold
300 mM sucrose solution. The cells were lysed with 200 Wl 10 mM
NaOH, 0.1% SDS and transferred into an Eppendorf tube. Radio-
activity was determined by Cerenkov counting and protein concen-
tration determined according to Bradford.
3. Results
3.1. Expression of Na,K-ATPase isoforms in brain endothelial
cells
Brain endothelial cells forming microcapillaries have both
high and low a⁄nity ouabain binding sites [10] and express at
least ¢ve di¡erent isoforms of the sodium pump [7]. To inves-
tigate the expression pattern of Na,K-ATPase isoforms in
bEnd4 cells, a mouse cell line derived form microcapillaries,
we performed RT-PCR analysis, using primers speci¢c for all
known isoforms. Fig. 1 shows the results of the RT-PCR
analysis in bEnd4 cells. We found highest expression for K1,
L1 and L3, moderate expression of L2, somewhat lower ex-
pression of K2 and a hardly detectable signal for K3. Provided
all proteins are translated from these transcripts, bEnd4 cells
have the potential to generate at least six (eventually nine)
di¡erent isoenzymes.
3.2. Ouabain sensitivity of brain endothelial cells
The weak expression of the K2 and K3 isoforms made it
necessary to determine whether these isoforms signi¢cantly
contributed to the total Na,K-ATPase activity in bEnd4 cells.
Since rodent K1 subunits have a several orders of magnitude
lower ouabain a⁄nity than K2 and K3 subunits, it is possible
to distinguish between these two classes by selectively inhibit-
ing high a⁄nity pump activity only. We, therefore, performed
an ouabain titration experiment as shown in Fig. 1A. The
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Fig. 1. Expression of Na,K-ATPase K and L subunit isoform genes
in bEnd4 cells. The PCR products were resolved on a 1% agarose
gel and visualised with ethidium bromide. The lengths of the prod-
ucts (in bp) are: K1, 1305; K2, 364; K3, 1441; L1, 619; L2, 569; L3,
792. Size markers (in bp) are indicated at the right margin.
M = marker lane.
Fig. 2. Ouabain concentration-dependent Na,K-ATPase activity in
bEnd4 cells. A: Ouabain titration experiment. bEnd4 cells in
24-well plates were preincubated with increasing concentrations of
ouabain for 2 min. 86Rb uptake was measured for 15 min in the
presence of the inhibitor. Na,K-ATPase activity is expressed in % of
the total ouabain-inhibitable ATPase activity. The results are the
mean þ S.D. of a quadruplicate determination of one experiment. B:
K activation of ouabain-sensitive Na,K-ATPase activity. bEnd4
cells were washed with K-free HBS and then incubated in bu¡er
containing increasing amounts of K. Na,K-ATPase activity was
determined in the presence of either 15 mM to inhibit both low and
high a⁄nity K subunit isoforms, or 10 WM ouabain to inhibit the
high a⁄nity K2 and K3 isoforms. The fraction of the low a⁄nity K1
isoform was calculated by subtracting the high a⁄nity activity from
total Na,K-ATPase activity. The activity is given in %. Data repre-
sent the mean þ S.D. of a quadruplicate determination of one ex-
periment repeated three times. Open symbols: K1 activity; closed
symbols: K2/3 activity.
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biphasic shape of the curve indicates that two a⁄nity popu-
lations are indeed present in bEnd4 cells. About 75^80% of
the activity can be assigned to the low a⁄nity K1 subunit-
containing enzymes with a Ki50 of 1.1U1034 M. The high
a⁄nity fraction accounts for the remaining 20^25% of oua-
bain inhibitable Na,K-ATPase activity with an apparent Ki50
of 3U1037 M. Thus, at about 10 WM ouabain concentration
K2/3-containing isoenzymes should be completely inactivated
whereas isoenzymes with K1 still retain nearly full activity.
The assumption was reinforced by similar experiments done
with human and porcine endothelial cells which have only
high a⁄nity ouabain binding sites : 10 WM ouabain completely
inhibited Na,K-ATPase activity (data not shown). To demon-
strate the fractional proportion of isoform-speci¢c pump ac-
tivities under such conditions by another approach, we per-
formed a K activation experiment. bEnd4 cells were
incubated either in the presence of increasing concentrations
of extracellular K. High and low a⁄nity ouabain-sensitive
Na,K-ATPase activity was determined with 10 WM or 15 mM
ouabain, respectively (Fig. 1B). In agreement with the ouabain
titration, isoenzymes consisting of the K1 isoform account for
about 80% of total pump activity.
3.3. Regulation of Na,K-ATPase activity by cGMP
To study the in£uence of cGMP on Na,K-ATPase activity
in bEnd4 cells, the membrane-permeable cGMP analogue 8-
Br-cGMP was used. Maximal inhibition of total ouabain-sen-
sitive Na,K-ATPase activity to 58% of the control was ob-
tained with 4 mM 8-Br-cGMP after 20 min of incubation at
37‡C (Fig. 2). When we added the PKG-speci¢c inhibitor
KT5823 at 2 WM concentration to the cells prior to incubation
with 8-Br-cGMP, the inhibitory e¡ect of cGMP was antagon-
ised. Incubation with KT5823 alone had no e¡ect on pump
activity. At the used concentration, this inhibitor has a more
than 8-fold selectivity for inhibition of PKG compared with
protein kinase A, indicating that the cGMP-induced inhibi-
tion is mediated through activation of PKG.
cGMP is mainly produced by the soluble guanylate kinase,
which is the major receptor of nitric oxide (NO). We therefore
used the NO donor nitroso-glutathione to study whether NO
can also modulate Na,K-ATPase activity. Similarly to 8-Br-
cGMP, NO reduces pump activity to 62% of the control level.
Addition of both nitroso-glutathione and 8-Br-cGMP at max-
imally e¡ective doses does not lead to a further inhibition of
Na,K-ATPase activity, indicating that the e¡ect of NO goes
through activation of guanylate cyclase.
In the next series of experiments the question of an isoform-
speci¢c in£uence of 8-Br-cGMP on ouabain-sensitive Na,K-
ATPase activity was addressed. bEnd4 cells were incubated
with 4 mM 8-Br-cGMP alone or in the presence of 10 WM
or 15 mM ouabain, respectively. To determine the K1 subunit-
associated Na,K-ATPase activity, the Na,K-ATPase activity
measured with 10 WM ouabain was subtracted from the activ-
ity obtained with 15 mM ouabain. K1-associated activity was
reduced to 45% of the control and could be prevented by
preincubation with 2 WM KT5823 (Fig. 3). We did not ob-
serve any signi¢cant in£uence of 8-Br-cGMP and KT5823 on
the activity of the K2/3 fraction, indicating that the e¡ect of
cGMP/PKG is restricted to the K1 isoform in bEnd4 cells
(Fig. 4).
4. Discussion
cGMP, activating PKG, reduces Na,K-ATPase activity in
kidney, a tissue expressing predominantly the Na,K-ATPase
K1 isoform, and increases pump activity in Purkinje neurons,
which mainly express K3. We therefore investigated whether
such opposite responses could be due to isoform-speci¢c reg-
ulation of Na,K-ATPase activity. For these purposes we used
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Fig. 3. Modulation of Na,K-ATPase activity in bEnd4 cells. bEnd4
cells were incubated for 15 min in HBS in the absence or presence
of 4 mM 8-Br-cGMP, 1 mM nitrosoglutathione, or 2 WM KT5823,
respectively, in the presence or absence of 15 mM ouabain. Oua-
bain-sensitive ATPase activity is expressed in % of the control activ-
ity measured with 15 mM ouabain without other additives. The re-
sults are the mean þ S.D. of a quadruplicate determination. The
experiment was repeated two times. *P6 0.05 compared with the
control using Student’s t-test.
Fig. 4. Isoform-speci¢c inhibition of Na,K-ATPase activity by
cGMP. bEnd4 cells were incubated for 15 min in HBS in the ab-
sence or presence of 4 mM 8-Br-cGMP, with or without 2 WM
KT5823, respectively, in the presence or absence of 15 mM or
10 WM ouabain. Ouabain-sensitive ATPase activity is expressed in
% of the control activity measured with 15 mM ouabain without
other additives. The fraction of the low a⁄nity K1 isoform was cal-
culated by subtracting the high a⁄nity activity from total Na,K-
ATPase activity. The results are the mean þ S.D. of a quadruplicate
determination derived from two experiments. *P6 0.05 compared
with the control using Student’s t-test.
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a brain endothelial cell line that simultaneously expresses dif-
ferent subunit isoforms.
The presence of three K and two L subunit isoforms in
microvessels has been demonstrated on the protein level [7].
The lesser amount of L proteins than K subunit proteins led
these authors to propose that L subunits could be rate limit-
ing, allowing to regulate the number of Na,K-ATPase isoen-
zymes in microvessels by solely controlling L subunit gene
expression. Our data suggest that L3, which was not yet
known at that time, might compensate the apparently lower
amount of L isoforms. Deduced from the expression level of L
isoform genes in bEnd4 cells, one would even predict an ex-
cess of L over K proteins. However, our data on mRNA ex-
pression do not directly demonstrate the quantities of the
respective protein. It is noteworthy that Zlokovic et al. [7]
measured an excess of L over K protein when quantifying
subunit isoforms in total brain extracts, suggesting that L
subunits are not rate-limiting in these tissues.
Little is known about the subunit composition of Na,K-
ATPase isoenzymes in cells expressing several isoforms simul-
taneously. Taking the relative strength of our PCR signals
and the ouabain sensitivity as a measure, the predominant
isoenzymes would be K1/L1 and K1/L3. In vitro reconstitution
experiments demonstrated that any combination of an K with
either L1 or L2 led to the generation of functionally active
enzymes with only subtly di¡erent enzymatic activities
[21,22], an indication that a cell’s isoenzyme repertoire is a
re£ection of the isoform expression level. However, reconsti-
tution experiments have provided biochemical evidence that
the interaction of L1 is stronger with K1 than with K2 or K3
[22] and L2 preferentially assembles with K2 rather than with
L1 [22,23]. Supporting these data is the observation that L2 is
found predominantly in association with K2 when isolated
from mouse brain [24]. Furthermore, in neurons, epithelial
and endothelial cells a compartmentalised distribution of K
subunit isoforms was observed [18,25,26]. In contrast, neuro-
nal cells in culture develop polarisation, but apparently dis-
tribute K isoforms in a random manner [27]. Thus, a selective
assembly and distribution of isoenzymes appears possible, but
may also depend on extracellular cues that direct pump dis-
tribution. The large extracellular domain of L subunit iso-
forms might play a role for such a mechanism (see e.g.
[24,28]).
The extent of inhibition of Na,K-ATPase activity by the
cGMP analogue 8-Br-cGMP and the NO donor nitroso-glu-
tathione is similar to the inhibitory action these compounds
exert in kidney [16,29]. Since kidney expresses predominantly
the K1 subunit isoform and the inhibition in bEnd4 cells is
restricted to the same isoform, a speci¢c inhibitory activity of
cGMP/PKG on K1 appears plausible, whereas the activity of
K2/K3 is not in£uenced. Owing to the very weak expression of
K3 it is likely that most of the activity is generated through
isoenzymes containing K2. The activating e¡ect of cGMP seen
in Purkinje neurons [18] supports a di¡erential behaviour of
the K2 and K3 isoforms too, since these cells predominantly
have K3. Alternatively, the e¡ects may include cell-speci¢c
pathways.
An important role in such pathways plays DARPP-32, a
dopamine- and cAMP-regulated phosphoprotein that, when
phosphorylated, inhibits protein phosphatase-1, ultimately
leading to inhibited Na,K-ATPase [30]. DARPP-32 is abun-
dantly present in renal tubule cells and involved in the dop-
amine-controlled regulation of Na excretion. Phosphoryla-
tion of DARPP-32 by NO and cGMP was demonstrated in
the brain [31] and by hormones and cGMP in the choroid
plexus [32]. Whether it is expressed in bEnd4 cells is currently
not known. Its presence has been demonstrated in ependymal
cells of circumventricular organs [33], thus providing indirect
evidence for the presence of DARPP-32 in tissues which con-
trol ion and £uid passage. We did not observe an e¡ect of
exogenously added cGMP and PKG on Na,K-ATPase activ-
ity when using a puri¢ed plasma membrane fraction, an in-
dication that pump inhibition is unlikely to be the result of a
direct action of PKG.
In conclusion, an isoform-speci¢c regulation of Na,K-ATP-
ase observed in endothelial cells, if existing in other cell types
with a complex isoform expression pattern, e.g. neurons, may
allow especially such cells accurate and perhaps locally re-
stricted control of ion gradients that are required to regulate
cell volume, £uid secretion and excitability.
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